Table 1 |
|||
|
Characteristics of patients |
|||
| Group 1 (N = 32) |
Group 2 (N = 29) |
||
| Characteristic |
Patients in monotherapy |
Patients in polytherapy |
*p |
|
|
|||
| Age, range (yr) |
27–69 |
27–70 |
|
| Age, mean ± SD (yr) |
48.3 ± 8.8 |
48.6 ± 11.3 |
0.771 |
| Duration of illness, mean ± SD (yr) |
10.8 ± 7.3 |
10.7 ± 9.1 |
0.950 |
| BMI, mean ± SD |
25.1 ± 5.5 |
27.9 ± 5.5 |
0.059 |
| **p |
|||
|
|
|||
| Smoking present, N (%) |
16 (50.0) |
15 (51.7) |
1.000 |
| Applied dose > DDD: |
|||
| Dose of AP > DDD, N (%) |
7 (21.9) |
8 (27.6) |
0.767 |
| Dose of AD > DDD, N (%) |
9 (28.1) |
11 (37.9) |
0.586 |
|
*p – 2-tailed t test; **p – 2-tailed Fisher Exact test; BMI – "body mass index"; DDD – "defined daily dose"; AP – antipsychotic; AD – antidepressant | |||
Sumić et al. Annals of General Psychiatry 2007 6:13 doi:10.1186/1744-859X-6-13 |
|||
